These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-000771-34 A 6-week multicentre, double-blind, randomised, placebo-controlled, parallel-group study to assess the efficacy and safety of rupatadine 10 and 20 mg in the treatment of Chronic Idiopathic Urticaria ... not-yet-due
No trial status on register 2004-001130-16 12 months long term safety and tolerability of Rupatadine 10 mg in the treatment of moderate-severe persistent allergic rhinitis. bad-data
Ongoing 2005-001412-50 Randomised, parallel clinical trial, to compare efficacy and safety of sucrose intravenous iron versus oral ferrous sulfate for the treatment of perioperative lack of iron in patients with colorrectal... not-yet-due
Completed, but no date 2005-004422-50 A placebo-controlled, double-blind, cross-over study with rupatadine 10 mg in 30 mosquito-bite allergic adult subjects bad-data
Ongoing 2005-005677-30 Evaluación de la eficacia clinica, seguridad y actividad farmacologica de UR-1505 en voluntarios con alergia a niquel: estudio aleatorizado, doble ciego, cruzado y con control activo not-yet-due
Completed, but no date 2006-003108-20 A DOUBLE BLIND, RANDOMISED, PARALLEL, PLACEBO-CONTROLLED, PILOT STUDY TO EVALUATE THE ANTI-INFLAMMATORY EFFECTS AND THE EFFICACY OF RUPATADINE 10 MG ON THE SYMPTOMS OF PERSISTENT ALLERGIC RHINITIS bad-data
Ongoing 2006-005169-21 Estudio piloto del uso del hierro endovenoso en el postoperatorio de cirugía mayor urológica not-yet-due
Ongoing 2007-004290-26 Evaluación del tratamiento con triflusal en pacientes con cardiopatía isquémica estable con no respuesta a AAS not-yet-due
Listed as ongoing, but also has a completion date 2007-005786-35 Estudio de prueba de concepto, cruzado, doble ciego, controlado con placebo para valorar si la Rupatadina 20 mg puede mejorar el umbral del tiempo critico de estimulación en pacientes con urticaria a ... 2008-08-23 bad-data
Completed, but no date 2008-005939-15 Efficacy and safety of rupatadine in persistent allergic rhinitis and health-related quality of life in children age 6-11 years: A randomized, double blind, placebo-controlled clinical trial. bad-data
Not reported 2010-021361-69 A multicenter, open-label study to assess pharmacokinetics, efficacy, tolerability and safety of Rupatadine in paediatrics patients (2-5 years old) with allergic rhinitis. 2011-03-30 due-trials
Ongoing 2010-023057-11 Efficacy and safety of rupatadine solution in the treatment of Chronic Spontaneous Urticaria (CSU) in paediatric patients (2-11 years old). not-yet-due
Exempt 2012-004900-37 A Phase I, Randomised, Double-blind, Placebo-controlled, Parallel group study to assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of oral Rupatadine in Healthy Japanese Subjects ... 2013-03-20 not-yet-due